INSP - Inspire Medical Syst...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $105.38 | Open | $106.20 |
| Volume | 178.1K | Market Cap | 2.812B |
| Yield | Last Dividend |
| The Daily Biotech Pulse: Opko Wins CDC C... | 07/21/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Abb... | |
| The Daily Biotech Pulse: Mallinckrodt Ge... | 07/16/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) Ato... | |
| The Daily Biotech Pulse: MediciNova On T... | 06/24/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) ACA... | |
| The Daily Biotech Pulse: Sanofi Expedite... | 06/23/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ju... | |
| Inspire Medical Systems (INSP) Expected ... | 04/28/20 |
| Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key... | |
| Why Inspire Medical Systems (INSP) Stock... | 04/09/20 |
| Inspire Medical Systems (INSP) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. | |
| Inspire Medical Systems EPS beats by $0.... | 02/25/20 |
| Inspire Medical Systems (NYSE:INSP): Q4 GAAP EPS of -$0.38 beats by $0.02. Revenue of $26.9M (+62.4% Y/Y) beats by $3.06M. Press Release | |
| The Daily Biotech Pulse: Merck's Keytrud... | 01/09/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: ASH Meeting Wra... | 12/10/19 |
| The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 9.) Acce... | |
| The Daily Biotech Pulse: Aurinia Rips Hi... | 12/05/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Dec. 4) A... | |
| The Daily Biotech Pulse: Roche's Tecentr... | 12/04/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 3) A... | |
| The Daily Biotech Pulse: Genmab-Novartis... | 08/30/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| Earnings Preview: Inspire Medical System... | 07/30/19 |
| Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t... | |
| The Daily Biotech Pulse: Roche Presents ... | 07/09/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 8) A... | |
| UnitedHealthcare To Cover Inspire Medica... | 07/08/19 |
| Inspire Medical Systems Inc (NYSE: INSP ) has announced UnitedHealth Group Inc (NYSE: UNH ) will cover its Inspire Therapy for the treatment of obstru... | |
| Inspire Medical Systems (INSP) Presents ... | 05/23/19 |
| No summary available. | |
| Inspire Medical Systems, Inc. (INSP) CEO... | 05/10/19 |
| Inspire Medical Systems Inc (NYSE:INSP) Q1 2019 Earnings Conference Call May 7, 2019 5:00 PM ET Company Participants Bob Yedid ??? Investor Relations,... | |
| Inspire Medical Systems, Inc. (INSP) Q1 ... | 05/08/19 |
| INSP earnings call for the period ending March 31, 2019. | |
| Inspire Medical Systems (INSP) Reports Q... | 05/07/19 |
| Inspire (INSP) delivered earnings and revenue surprises of 10.26% and 13.24%, respectively, for the quarter ended March 2019. Do the numbers hold clue... | |
| Inspire Medical Systems beats by $0.05, ... | 05/07/19 |
| Inspire Medical Systems (INSP): Q1 GAAP EPS of -$0.35 beats by $0.05. Revenue of $16.25M (+61.9% Y/Y) beats by $1.26M. Shares -1.3%. Press Release | |
| Inspire Medical Systems (INSP) May Repor... | 04/30/19 |
| Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t... | |
| Inspire Medical Systems, Inc. Announces ... | 04/25/19 |
| MINNEAPOLIS, April 25, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP ) ("Inspire"), a medical technology company focused on the d... | |
| Inspire Medical Systems (INSP) SVB Leeri... | 02/28/19 |
| No summary available. | |
| Inspire Medical Systems, Inc. (INSP) CEO... | 02/27/19 |
| No summary available. | |
| Inspire Medical Systems beats by $0.11, ... | 02/26/19 |
| No summary available. | |
| Beating the Market With Medical-Device S... | 02/13/19 |
| Vivian Wohl, co-manager of the Federated Kaufman Small Cap fund, digs deep when researching medical devices. Why she likes the stocks of Inspire Medic... | |
| Strong Buy rating | 08/06/20 |
| Wells Fargo maintains Overweight rating and raises Price Target from $115.00 to $125.00 | |
| Strong Buy rating | 08/05/20 |
| SVB Leerink maintains Outperform rating and raises Price Target from $110.00 to $120.00 | |
| Buy rating | 07/15/20 |
| Goldman Sachs initiates coverage with Buy rating and announces Price Target of $148.00 | |
| Strong Buy rating | 06/29/20 |
| SVB Leerink maintains Outperform rating and raises Price Target from $85.00 to $110.00 | |
| Strong Buy rating | 06/18/20 |
| Piper Sandler maintains Overweight rating and raises Price Target from $74.00 to $98.00 | |
| Strong Buy rating | 05/26/20 |
| Wells Fargo maintains Overweight rating and raises Price Target from $81.00 to $95.00 | |
| Date | 2020-08-04 (AMC) | Est. (EPS/Rev.) | ($1.10)/ 7.85M |
| Actual (EPS/Rev.) | $-0.88/ $12.18 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| High Growth Stocks- Long only | Srini Donapati | 67.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
